The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Serotonin as a Modulator of Glutamate- and GABA-Mediated Neurotransmission: Implications in Physiological Functions and in Pathology
Open accessAbstract
The neurotransmitter serotonin (5-HT), widely distributed in the central nervous system (CNS), is involved in a large variety of physiological functions. In several brain regions 5-HT is diffusely released by volume transmission and behaves as a neuromodulator rather than as a "classical" neurotransmitter. In some cases 5-HT is co-localized in the same nerve terminal with other neurotransmitters and reciprocal interactions take place. This review will focus on the modulatory action of 5-HT on the effects of glutamate and gamma-amino-butyric acid (GABA), which are the principal neurotransmitters mediating respectively excitatory and inhibitory signals in the CNS. Examples of interaction at pre-and/or post-synaptic levels will be illustrated, as well as the receptors involved and their mechanisms of action. Finally, the physiological meaning of neuromodulatory effects of 5-HT will be briefly discussed with respect to pathologies deriving from malfunctioning of serotonin system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
Metaplasticity: the plasticity of synaptic plasticity
Abraham, W. C., & Bear, M. F. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80018-x · Cited by 1,776
PEROUTKA, S. J., & SNYDER, S. H. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13812-1 · Cited by 1,360
The developmental role of serotonin: news from mouse molecular genetics
Gaspar, P., Cases, O., & Maroteaux, L. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1256 · Cited by 1,297
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., & Saxena, P. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90207-8 · Cited by 1,258
The cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182
Cited by
Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Biomimetic 3D-printed scaffolds for spinal cord injury repair
Koffler, J., Zhu, W., Qu, X., Platoshyn, O., Dulin, J. N., Brock, J., Graham, L., Lu, P., Sakamoto, J., Marsala, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0296-z · Cited by 708
An aberrant precision account of autism
Lawson, R. P., Rees, G., & Friston, K. J. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00302 · Cited by 641
Karimi-Abdolrezaee, S., Eftekharpour, E., Wang, J., Schut, D., & Fehlings, M. G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3111-09.2010 · Cited by 363
Phasic acetylcholine release and the volume transmission hypothesis: time to move on
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2635 · Cited by 344
Serotonin Receptors – From Molecular Biology to Clinical Applications
PYTLIAK, M., VARGOVÁ, V., MECHÍROVÁ, V., & FELŠÖCI, M. (2011) · Physiological Research · doi:10.33549/physiolres.931903 · Cited by 318
Understanding wiring and volume transmission
Agnati, L. F., Guidolin, D., Guescini, M., Genedani, S., & Fuxe, K. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.03.003 · Cited by 287
The serotonergic system and cognitive function
Švob Štrac, D., Pivac, N., & Mück-Šeler, D. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0007 · Cited by 285
Discovering imaging endophenotypes for major depression
Hasler, G., & Northoff, G. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.23 · Cited by 274
The serotonin transporter in psychiatric disorders: insights from PET imaging
Spies, M., Knudsen, G. M., Lanzenberger, R., & Kasper, S. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00232-1 · Cited by 177
Reduced occipital GABA in Parkinson disease with visual hallucinations
Firbank, M. J., Parikh, J., Murphy, N., Killen, A., Allan, C. L., Collerton, D., Blamire, A. M., & Taylor, J.-P. (2018) · Neurology · doi:10.1212/wnl.0000000000006007 · Cited by 103
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“Since then, many of the studies showed that ANX is a GABAergic and serotonergic modulated condition (as reviewed by [35]).”
BackgroundToward a glutamate hypothesis of frontotemporal dementia
Benussi, A., Alberici, A., Buratti, E., Ghidoni, R., Gardoni, F., Di Luca, M., Padovani, A., & Borroni, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00304 · Cited by 90
“5-HT has been shown to differently modify glutamate mediated effects, acting on distinct 5-HT receptor subtypes both at the pre-synaptic and post-synaptic site and in different brain regions: in the frontal cortex glutamate release is inhibited by serotonin whereas in the prefrontal cortex serotonin enhances glutamate…”
BackgroundFrodl, T., Szyf, M., Carballedo, A., Ly, V., Dymov, S., Vaisheva, F., Morris, D., Fahey, C., Meaney, J., Gill, M., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140180 · Cited by 86
Vortioxetine for cognitive enhancement in major depression: From animal models to clinical research
Bennabi, D., Haffen, E., & Van Waes, V. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00771 · Cited by 75
“10 GABA, the main inhibitory neurotransmitter in the brain, exerts inhibitory action on the glutamatergic excitatory neurotransmission system and key regulators of cognitive processing (64).”
BackgroundKomlósi, G., Molnár, G., Rózsa, M., Oláh, S., Barzó, P., & Tamás, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2618-12.2012 · Cited by 57
Zhao, J., Tian, H., Song, H., Wang, X., Luo, T., Ai, L., Fang, Y., Zhao, J., Chao-ke-tu, S., & Li, Z. (2019) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2019/7124318 · Cited by 34
Rich, M. T., & Torregrossa, M. M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.09.003 · Cited by 27
Saito, Y., Matsumoto, M., Yanagawa, Y., Hiraide, S., Inoue, S., Kubo, Y., Shimamura, K., & Togashi, H. (2013) · Synapse · doi:10.1002/syn.21621 · Cited by 26
Milic, J., Jovic, S., & Sapic, R. (2025) · Genes · doi:10.3390/genes16050487 · Cited by 19
Metadata
- Authors
- Ciranna, L.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-04-01
- Volume
- 4
- Issue
- 2
- Pages
- 101-114
- ISSN
- 1570-159X (ISSN-L)
- OpenAlex
- W2024747286
- Cited by
- 336
- References
- 173
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.